IP Library Patent Application 15513887
Patent Application
App. No. 15/513,887

STERILIZATION COMPOSITIONS AND METHODS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/513,887
Abstract

A biological indicator is provided for measuring the effectiveness of a sterilization procedure. The biological indicator comprises a carrier having a microorganism and at least one of a humectant, anti-agglomerating agent or surfactant disposed thereon, the carrier having a solidity of greater than 5%. Various embodiments of a device, kits and methods are disclosed.

Claims (35)

1 . A biological indicator for measuring effectiveness of a sterilization procedure, the biological indicator comprising: a carrier having a microorganism and at least one of a humectant, anti-agglomerating agent or surfactant disposed thereon, the carrier having a solidity of greater than 5%.

2 . A biological indicator according to claim 1 , wherein the humectant, anti-agglomerating agent or surfactant comprises glycerol.

3 . A biological indicator according to claim 1 , wherein the carrier has the microorganism and the humectant, anti-agglomerating agent or surfactant inoculated thereon.

4 . A biological indicator according to claim 1 , wherein the humectant comprises glycerol, propylene glycol, hexylene glycol, butylene glycol, glyceryl triacetate, neoagarobiose, sorbitol, xylitol, maltitol, polymeric polyols such as polydextrose, quillaia, urea, aloe vera gel, MP diol, lactic acid, honey and/or lithium chloride.

5 . A biological indicator according to claim 1 , wherein the anti-agglomerating agent comprises glycerol, polyethylene glycol, talc, titanium dioxide, magnesium stearate and/or silicon dioxide.

6 . A biological indicator according to claim 1 , wherein the surfactant comprises glycerol, polyethoxylated castor oil, a polysorbate, a sorbitan ester, a polyoxyethylene fatty acid ester, a polyoxyethylene fatty acid ether, a polyoxyethylene alkyl ether, an ethoxylated fatty acid, long-alkyl-chain sulfonates, alkyl aryl sulfonates, dialkyl sodium sulfosuccinates, alkyl sulfates, quaternary ammonium salts, fatty alcohols, such as lauryl, cetyl and stearyl alcohols; glyceryl esters such as mono-, di- and triglycerides; and fatty acid esters of fatty alcohols and alcohols such as propylene glycol, polyethylene glycol, sorbitan, sucrose and cholesterol, polyoxyethylene glyceryl, steroidal esters and/or polyoxypropylene esters.

7 . A biological indicator according to claim 1 , wherein (i) the carrier comprises glass or paper or (ii) the carrier comprises fibers having a diameter of about 1 to 500 microns.

8 . A biological indicator according to claim 3 , wherein the inoculum comprises 0.5% glycerol.

9 . A biological indicator according to claim 3 , wherein the inoculum comprises 1.0% glycerol.

10 . A biological indicator according to claim 3 , wherein the inoculum comprises 2.0% glycerol.

11 . A biological indicator according to claim 3 , wherein the inoculum comprises 5.0% glycerol.

12 . A biological indicator according to claim 3 , wherein the inoculum comprises (i) 0.5% glycerol and 99.5% sterile fluid; (ii) 1.0% glycerol and 99.0% sterile fluid; (iii) 2.0% glycerol and 98.0% sterile fluid; or (iv) 5.0% glycerol and 95.0% sterile fluid.

13 . A biological indicator according to claim 1 , wherein the microorganism comprises spores.

14 . A biological indicator according to claim 13 , wherein the spores comprise Bacillus, Clostridium, Neurospora, Candida, and, and/or Cryptosporidium.

15 . A biological indicator according to claim 13 , wherein the spores comprise Geobacillus stearothermophilus and/or Bacillus atrophaeus.

16 . A biological indicator for measuring effectiveness of a sterilization procedure, the biological indicator comprising: a container comprising growth media and a carrier separated from the growth media, the carrier comprising at least one of a humectant, anti-agglomerating agent or surfactant and spores inoculated thereon.

17 . A biological indicator according to claim 16 , wherein the container comprises a member configured to move the carrier from a first position separated from the growth media to a second position to contact the growth media.

18 . A biological indicator according to claim 16 , wherein the media is disposed within a crushable vial.

19 . A biological indicator according to claim 16 , wherein the humectant, dispersant, anti-agglomerating agent or surfactant comprises glycerol.

20 . A biological indicator according to claim 16 , wherein the humectant comprises glycerol, polyethylene glycol, propylene glycol, hexylene glycol, butylene glycol, glyceryl triacetate, neoagarobiose, sorbitol, xylitol, maltitol, polymeric polyols such as polydextrose, quillaia, urea, aloe vera gel, MP diol, lactic acid, honey and/or lithium chloride.

21 . A biological indicator according to claim 16 , wherein the anti-agglomerating agent comprises glycerol, polyethylene glycol, polyethtalc, titanium dioxide, magnesium stearate and/or silicon dioxide.

22 . A biological indicator according to claim 16 , wherein the surfactant comprises glycerol, polyethoxylated castor oil, a polysorbate, a sorbitan ester, a polyoxyethylene fatty acid ester, a polyoxyethylene fatty acid ether, a polyoxyethylene alkyl ether, an ethoxylated fatty acid, long-alkyl-chain sulfonates, alkyl aryl sulfonates, dialkyl sodium sulfosuccinates, alkyl sulfates, quaternary ammonium salts, fatty alcohols such as lauryl, cetyl and stearyl alcohols; glyceryl esters such as mono-, di- and triglycerides; and fatty acid esters of fatty alcohols and other alcohols such as propylene glycol, polyethylene glycol, sorbitan, sucrose and cholesterol, polyoxyethylene glyceryl, steroidal esters and/or polyoxypropylene esters.

23 . A biological indicator according to claim 16 , wherein the spores comprise Bacillus, Clostridium, Neurospora, Candida, and, and/or Cryptosporidium.

24 . A biological indicator according to claim 16 , wherein the spores comprise Geobacillus stearothermophilus and/or Bacillus atrophaeus.

25 . A method for determining effectiveness of a sterilization procedure with a biological indicator, the method comprising: subjecting the biological indicator to a sterilization cycle, the biological indicator comprising a deformable container having a crushable vial disposed therein comprising growth media and a carrier separated from the crushable vial but within the deformable container, wherein the carrier comprises at least one of a humectant, anti-agglomerating agent or surfactant and spores; activating the biological indicator by applying pressure to said deformable container to crush the vial so as to allow the growth media and the spores of the carrier to come into contact with each other; and incubating the biological indicator for a predetermined period of time to permit any growth of the spores surviving said sterilization cycle to grow in the growth media, wherein the growth provides a determination of the effectiveness of the sterilization procedure.

26 . A method according to claim 25 , wherein the humectant, anti-agglomerating agent or surfactant comprises glycerol.

27 . A method according to claim 25 , wherein the sterilization procedure comprises contacting the spores with hydrogen peroxide sterilization, steam sterilization and ethylene oxide sterilization.

28 . A method according to claim 25 , wherein the sterilization procedure comprises contacting the spores with hydrogen peroxide or peracetic acid.

29 . A method according to claim 25 , wherein the biological indicator further comprises a vented cap which allows a sterilant from the sterilization procedure to enter the deformable container and contact the spores on the carrier during the sterilization cycle.

30 . A method according to claim 25 , wherein a positive indication of spore growth is shown via a pH indicator and the pH indicator changes color in the growth media.

31 . A kit for determining effectiveness of a sterilization procedure, the kit comprising:

a biological indicator comprising a container having a vial disposed therein comprising growth media and a carrier separated from the vial but within the container, wherein the carrier comprises at least one of a humectant, anti-agglomerating agent or surfactant and a microorganism inoculated thereon.

32 . A kit according to claim 31 , wherein the humectant, anti-agglomerating agent or surfactant comprises glycerol.

33 . A kit according to claim 31 , wherein the kit further comprises a set of instructions on how to operate the biological indicator.

34 .- 37 . (canceled)

Assignments (8)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jun 3, 2021
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: SPS MEDICAL SUPPLY CORP.
Reel/Frame 056542/0889 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jun 3, 2021
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: MEDIVATORS INC.
Reel/Frame 056469/0366 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 9, 2019
From: MEDIVATORS INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 050312/0332 →
CORRECTIVE ASSIGNMENT TO CORRECT THE WRONG ASSIGNMENT DOCUMENT WAS PREVIOUSLY FILED AND RECORDED ON JUNE 7, 2018 PREVIOUSLY RECORDED ON REEL 046316 FRAME 0525. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 6, 2019
From: DOYLE, SHAWN; NOLAN, MIKE
To: SPS MEDICAL SUPPLY CORP.
Reel/Frame 048266/0977 →
CORRECTIVE ASSIGNMENT TO CORRECT THE WRONG ASSIGNMENT DOCUMENT WAS PREVIOUSLY FILED AND RECORDED ON JUNE 18, 2018 PREVIOUSLY RECORDED ON REEL 046377 FRAME 0380. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT ASSIGNMENT IS ATTACHED, ASSIGNING CURRENT APPLICATION TO SPS MEDICAL SUPPLY CORP.. Recorded Feb 6, 2019
From: DOYLE, SHAWN; NOLAN, MIKE
To: SPS MEDICAL SUPPLY CORP.
Reel/Frame 048266/0956 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jun 28, 2018
From: SPS MEDICAL SUPPLY CORP.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 046452/0964 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2018
From: WANG, DANIEL; CHEN, DENGHUI; TAO, BO; YUE, BO; ZHU, YONG
To: CROSSTEX INTERNATIONAL, INC.; PAC-DENT INTERNATIONAL, INC.
Reel/Frame 046377/0380 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2018
From: WANG, DANIEL; CHEN, DENGHUI; TAO, BO; YUE, BO; ZHU, YONG
To: CROSSTEX INTERNATIONAL, INC.
Reel/Frame 046316/0525 →